610309-89-2 Usage
Description
Carvedilol Phosphate is a pharmaceutical compound that serves as the active ingredient in medications used to treat various cardiovascular conditions. It is a beta-blocker and vasodilator, which means it helps to relax blood vessels and reduce the workload on the heart, thereby improving its function and overall cardiovascular health.
Uses
Used in Cardiovascular Medicine:
Carvedilol Phosphate is used as a therapeutic agent for the treatment of congestive heart failure, left ventricular dysfunction following a myocardial infarction, and management of hypertension. Its dual action as a beta-blocker and vasodilator helps to improve heart function, reduce the symptoms of heart failure, and lower blood pressure, providing significant benefits for patients with these conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 610309-89-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,1,0,3,0 and 9 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 610309-89:
(8*6)+(7*1)+(6*0)+(5*3)+(4*0)+(3*9)+(2*8)+(1*9)=122
122 % 10 = 2
So 610309-89-2 is a valid CAS Registry Number.
InChI:InChI=1/2C24H26N2O4.2H3O4P.H2O/c2*1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20;2*1-5(2,3)4;/h2*2-12,17,25-27H,13-16H2,1H3;2*(H3,1,2,3,4);1H2
610309-89-2Relevant articles and documents
PROCESS FOR THE PREPARATION OF CARVEDILOL DIHYDROGEN PHOSPHATE HEMIHYDRATE AND PHARMACEUTICAL COMPOSITIONS THEREOF
-
Page/Page column 2, (2009/05/28)
There is provided processes for preparing carvedilol dihydrogen phosphate hemihydrate, which processes include at least one of the steps of: (a) providing a solution of carvedilol in a mixture of organic solvent (s) and/or water; (b) adding a phosphonatin
NOVEL POLYMORPHIC FORMS OF CARVEDILOL DIHYDROGEN PHOSPHATE AND PROCESS FOR PREPARING THE SAME
-
Page/Page column 8, (2008/12/06)
The present invention provides novel crystalline polymorphic forms and amorphous form of carvedilol dihydrogen phosphate characterized by different solid state techniques. The novel processes for their preparation are also disclosed.
CARVEDILOL FREE BASE, SALTS, ANHYDROUS FORMS OR SOLVATE THEREOF, CORRESPONDING PHARMACEUTICAL COMPOSITIONS, CONTROLLED RELEASE FORMULATIONS, AND TREATMENT OR DELIVERY METHODS
-
Page/Page column 97, (2008/06/13)
The present invention also relates to carvedilol free base, carvedilol salts, anhydrous forms, or solvates thereof, corresponding pharmaceutical compositions or controlled release formulations, and delivery or dosing methods of carvedilol forms to the low
